You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Fighting Post-COVID and ME/CFS – development of curative therapies
|
---|---|
Published in |
Frontiers in Medicine, June 2023
|
DOI | 10.3389/fmed.2023.1194754 |
Pubmed ID | |
Authors |
Carmen Scheibenbogen, Judith Theresia Bellmann-Strobl, Cornelia Heindrich, Kirsten Wittke, Elisa Stein, Christiana Franke, Harald Prüss, Hannah Preßler, Marie-Luise Machule, Heinrich Audebert, Carsten Finke, Hanna Gwendolyn Zimmermann, Birgit Sawitzki, Christian Meisel, Markus Toelle, Anne Krueger, Anna C. Aschenbrenner, Joachim L. Schultze, Marc D. Beyer, Markus Ralser, Michael Mülleder, Leif Erik Sander, Frank Konietschke, Friedemann Paul, Silvia Stojanov, Lisa Bruckert, Dennis M. Hedderich, Franziska Knolle, Gabriela Riemekasten, Maria J. G. T. Vehreschild, Oliver A. Cornely, Uta Behrends, Susen Burock |
X Demographics
The data shown below were collected from the profiles of 542 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 118 | 22% |
United States | 20 | 4% |
Switzerland | 11 | 2% |
Austria | 10 | 2% |
United Kingdom | 10 | 2% |
Norway | 7 | 1% |
Canada | 4 | <1% |
Australia | 4 | <1% |
France | 4 | <1% |
Other | 18 | 3% |
Unknown | 336 | 62% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 495 | 91% |
Scientists | 23 | 4% |
Practitioners (doctors, other healthcare professionals) | 17 | 3% |
Science communicators (journalists, bloggers, editors) | 5 | <1% |
Unknown | 2 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 5 | 26% |
Student > Ph. D. Student | 2 | 11% |
Researcher | 2 | 11% |
Professor > Associate Professor | 1 | 5% |
Professor | 1 | 5% |
Other | 0 | 0% |
Unknown | 8 | 42% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 5 | 26% |
Medicine and Dentistry | 2 | 11% |
Philosophy | 1 | 5% |
Computer Science | 1 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Other | 2 | 11% |
Unknown | 7 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 365. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#88,903
of 25,815,269 outputs
Outputs from Frontiers in Medicine
#40
of 7,330 outputs
Outputs of similar age
#2,056
of 384,887 outputs
Outputs of similar age from Frontiers in Medicine
#3
of 335 outputs
Altmetric has tracked 25,815,269 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,330 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 384,887 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 335 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.